ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 183,95
0,27%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intra Cellular Therapies Inc (ITCI)

  7. Intra Cellular Therapies Inc (ITCI) Actualités

ITCI Intra Cellular Therapies Inc

67,77
-0,64 (-0,94%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Intra Cellular Therapies Inc ITCI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,64 -0,94% 67,77 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
67,66 66,574 69,28 67,77 68,41
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/6/202414:00GLOBEIntra-Cellular Therapies to Present at the 45th Annual..
29/5/202414:00GLOBEIntra-Cellular Therapies to Present at the Jefferies Global..
23/5/202414:00GLOBEIntra-Cellular Therapies Highlights Data Presentations at..
08/5/202414:00GLOBEIntra-Cellular Therapies to Participate in Two Upcoming..
07/5/202413:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:40EDGAR2Form 8-K - Current report
07/5/202413:30GLOBEIntra-Cellular Therapies Reports First Quarter 2024..
30/4/202414:00GLOBEIntra-Cellular Therapies to Host First Quarter 2024..
24/4/202422:01GLOBEIntra-Cellular Therapies Announces Closing of $575 Million..
18/4/202402:46GLOBEIntra-Cellular Therapies Prices Public Offering of Common..
16/4/202422:06GLOBEIntra-Cellular Therapies Announces Proposed Public Offering..
16/4/202413:00GLOBEIntra-Cellular Therapies Announces Positive Phase 3 Topline..
19/3/202413:30GLOBEIntra-Cellular Therapies Announces Executive Appointments..
11/3/202421:52EDGAR2Form 144 - Report of proposed sale of securities
11/3/202421:38EDGAR2Form 144 - Report of proposed sale of securities
11/3/202421:30EDGAR2Form 144 - Report of proposed sale of securities
08/3/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:44EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:27EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:19EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:17EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:00GLOBEIntra-Cellular Therapies to Participate in Three Upcoming..
06/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202414:00GLOBEIntra-Cellular Therapies to Present at the 44th Annual TD..
26/2/202422:59EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
26/2/202422:55EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:46EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:33EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
22/2/202413:42EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:39EDGAR2Form 8-K - Current report
22/2/202413:30GLOBEIntra-Cellular Therapies Reports Fourth Quarter And..
08/2/202414:00GLOBEIntra-Cellular Therapies to Host Fourth Quarter and Full..
06/2/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:47EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:41EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:39EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
ITCI
Intra Cellular Therapies
BIT
P1XHF7
NLBNPIT1XHF7 20240920 45
NASDAQ
FPBTX
Future Path 529 JPMorgan...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés